16-18 MAY 2024

A journey through brachytherapy

Joanne Alfieri, MD

Joanne Alfieri, MD

McGill University Health Center

J Joanne Alfieri is an associate professor in the Department of Oncology, McGill University since February 2012. She is a radiation oncologist who specializes in the treatment of gynaecological and gastrointestinal malignancies at the McGill University Health Centre. Dr. Alfieri earned her medical degree and her post-graduate radiation oncology training at McGill. She completed a Post-graduate Fellowship in Gynaecology Oncology and MRI-guided Brachytherapy at the Peter MacCallum Cancer Centre in Melbourne, Australia.  Dr. Alfieri is the lead for the gynecological site group as well as the brachytherapy lead for the MUHC. She initiated the MRI-guided brachytherapy program at McGill, and her current research interests lie in the evaluation of this program with the aim of improving the long-term outcomes and minimizing treatment-related toxicity in gynaecological cancer patients as well as in investigating alternate treatment options for locally advanced cervix cancer.  She has a keen interest in medical education and is the post-graduate residency training Program Director for radiation oncology since February 2015 as well as Associate Chair (Education) for the Gerald Bronfman Department of Oncology of McGill University where oversees undergraduate, graduate, and post-graduate training programs in medical, surgical and radiation oncology. Merci!      

May 16, 2024 Sessions
14:30 - 15:30 Cervix cancer MRI workflow (part 1)
May 17, 2024 Sessions
15:40 - 16:40 Cervix cancer MRI workflow (part 2)
Lijia Aviles, MD

Lijia Aviles, MD

Bolivia

Dr. Avilés is a Bolivian medical graduate from the Universidad Mayor de San Andrés (UMSA) and specialized as a Radiation Oncologist at the University of Buenos Aires (UBA).  She completed an Observership at the Massachusetts General Hospital and Dana Farber Cancer Center in Boston.  She holds a Master's degree in High Technologies of Radiotherapy from Madrid with the Madrilenian Oncology Group.  Additionally, she earned a Master's degree in Radiosurgery from the Complutense University of Madrid.  After nearly 10 years of working in prestigious hospitals in Buenos Aires, she returned to Bolivia in 2017 where she pioneered the establishment of the country's first high-tech cancer center.  Together with her team, she started the advanced brachytherapy program in 2021 and performed the first Interstitial implant with Venezia in the country in 2023.  Dr. Avilés is a board member of ALATRO (Latin American Radiation Therapy Association), has publications in high-impact scientific journals, and is invited to various international conferences as a speaker and representative of her country.    Currently, she serves as the Director of Radiation Oncology at Oncoservice Clinic and is the founder and president of the Latin American Association of Women in Oncology (ALAMO).  

May 18, 2024 Sessions
10:20 - 10:40 Improving global access to gyn brachytherapy
Boris Bahoric, MD

Boris Bahoric, MD

Jewish General Hospital

Dr. Bahoric completed his medical school in Rijeka, Croatia. He completed his Royal College Fellowship Program in Radiation oncology in Toronto. He works as staff radiation oncologist at the Jewish General Hospital in Montreal. He is assistant professor at McGill University. Apart from teaching he is involved in various administrative activities. His areas of interest and expertise are the gynecological, genitourinary and hematological malignancies. Particularly, he is interested in brachytherapy. He offers both intracavitary and interstitial for gynecological malignancies. He performs adjuvant accelerated partial breast irradiation via interstitial brachytherapy. Dr. Bahoric participates in nationwide studies in prostate cancer. As part of the studies he offers and performs HDR prostate brachytherapy. He is past president of Canadian Brachytherapy Group and is still active participant in this group.

Luc Beaulieu, Physicien médical

Luc Beaulieu, Physicien médical

Centre hospitalier universitaire de Québec

Dr. Beaulieu is a full professor, Director of the CAMPEP graduate program and also Director of the Cancer Research Centre at Université Laval. He served on the Board of the Canadian Organization of Medical Physicists as President Elect, President and Past President (2010-2016). He is a member of the AAPM Brachytherapy Subcommittee as well as two associated Working Groups (Robotics and Clinical Applications), is the Chair of TG317 on tracking technology for brachytherapy, a member of the ESTRO In Vivo dosimetry working group, was the Chair of TG-186 and until recently led the AAPM/ESTRO/ABG Working Group on Model-Based Dose Calculations in Brachytherapy. He has mentored over 150 highly qualified personals, published 220 peer-reviewed manuscripts and 465 refereed abstracts at national and international meetings. He is a recognized expert on topics related to scintillation dosimetry and brachytherapy. Luc

May 16, 2024 Sessions
14:30 - 15:30 LDR prostate brachytherapy (MV)
May 17, 2024 Sessions
13:30 - 13:50 Multi-Criteria Optimization for HDR Cervical Brachytherapy

Francine Breton, Patient Advocate

...

May 18, 2024 Sessions
08:50 - 08:55 Patient insight in brachytherapy
Dominique Buteau, MD

Dominique Buteau, MD

Hôtel-Dieu de Lévis

Dr. Dominique Buteau completed certification in emergency medicine from the College of Family Medicine of Canada in 1996. Since then, he has practiced emergency medicine full-time. Since 2002, he has also worked in hyperbaric medicine and diving medicine. He has been a member of the emergency department and the hyperbaric medicine department of the Hôtel-Dieu de Lévis since July 2002. He holds a position as a Clinical Associate Professor in the Department of Family Medicine and from Laval University. Dr. Buteau has been the Medical Director of the Centre de Médecine de Plongée du Québec since 2009 and has also held the position of Chief Physician of the Hyperbaric Medicine Department of the Hôtel-Dieu de Lévis since January 2013. From 2010 to 2018, Dr. Buteau was involved on the Board of Directors of the Canadian Association of Hyperbaric and Underwater Medicine, serving as President of the Association from 2014 to 2016. He is currently involved at the national level.

Albert Chang, MD

Albert Chang, MD

UCLA Radiation Oncology

Dr. Albert J. Chang, MD, PhD is the Vice Chair of Surgical Services and Director of Brachytherapy at the University of California, Los Angeles.  He is a radiation oncologist that specializes in brachytherapy to all sites of the body.  He is actively involved in the American Brachytherapy Society and is the Chair of the Advisory Council.  His research interests are in optimizing brachytherapy with the use of systemic treatments.   

May 18, 2024 Sessions
08:00 - 08:20 Interstitial Brachytherapy for Lung Tumors
Yannick Chassé, Technologue

Yannick Chassé, Technologue

Hôpital Charles Lemoyne

Yannick Chassé graduated from Ahuntsic College in 2013 and his a member of the brachytherapy team at the Hôpital Charles Lemoyne since 2020.

May 17, 2024 Sessions
15:40 - 16:40 Patient welfare during brachytherapy

Robert Den, MD

Alpha-Tau Medical LTD

Dr. Robert Den is an ABR-certified Radiation Oncologist and has served as Chief Medical Officer of Alpha Tau for the past five years. He has a BS from Yale University, a medical doctorate from Harvard Medical School, and nearly 17 years of experience as an Associate Professor at Thomas Jefferson University focusing on genitourinary and gynecological malignancies.  Dr. Den is a member of NRG Oncology and serves as the translational PI for two phase III trials.  He also chaired the Jefferson Data and Monitoring Committee and served as a member of the Institutional Review Board.

May 16, 2024 Sessions
16:00 - 16:30 A novel locally targeted alpha therapy
Talar Derashodian, MD

Talar Derashodian, MD

Université de Sherbrooke - Hôpital Charles Lemoyne

Dr Derashodian is a radiation oncologist working at Centre Intégré de Cancérologie de la Montérégie, at Charles LeMoyne hospital. She graduated from Université de Montreal’s medical school in 2005. She then completed her residency in radiation oncology at Université Laval. She pursued her academic training at University of Miami with a fellowship in Urologic cancers under the supervision of Dr Alan Pollack. Her main areas of expertise include urologic, gynecologic, and head and neck tumors, as well as general brachytherapy.

May 16, 2024 Sessions
14:30 - 15:30 3-D plesiotherapy for skin (MV)
May 17, 2024 Sessions
09:50 - 10:00 Complication And Trauma During Gyn Brachytherapy
15:40 - 16:40 Skin lip cancer brachytherapy
Christopher Deufel, Physicien médical

Christopher Deufel, Physicien médical

Mayo Clinic

Dr. Christopher Deufel is the chair of research for the Division of Medical Physics and practice leader for Brachytherapy in the Department of Radiation Oncology at the Mayo Clinic, in Rochester, Minnesota.  Dr. Deufel received his Ph.D. in experimental physics from Cornell University and completed residency training in therapeutic medical physics at the Mayo Clinic.  He is currently the secretary for the American Brachytherapy Society and has served the ABS board of directors for the past three years.  At the Mayo Clinic, he supervises physics resident education in brachytherapy and conducts research in brachytherapy applicator design, clinical brachytherapy techniques, and radiation treatment planning methods. His work has been published Nature Methods, Radiotherapy and Oncology, the International Journal of Radiotherapy and Oncology Biology Physics, Physics in Medicine and Biology, the Brachytherapy Journal, and the Journal of Applied Clinical Medical Physics.   

Philip Devlin, MD

Philip Devlin, MD

Dana-Farber/Brigham and Women’s Cancer Center

Phillip M. Devlin, MD, FACR, FASTRO, FFRRCSI(Hon) is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Devlin earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996.   In addition to lecturing extensively both nationally and internationally, Dr. Devlin has more than 100 published manuscripts and book chapters, and is editor of the text, Brachytherapy: Applications and Techniques, now in its second edition. He is a past President of the Massachusetts Radiological Society and was previously a member of the Board of Directors of the American Society for Radiation Oncology (ASTRO). In 2008, he was named a Fellow of the American College of Radiology (FACR), and in 2013 he became both a Fellow of ASTRO (FASTRO) and a Faculty of Radiology Honorary Fellow in the Royal College of Surgeons of Ireland (FFRRCSI[Hon]) and a Fellow of the American Brachytherapy Society. Dr. Devlin led two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project. His current research focus is on radioreponsiveness and gene expression in cutaneous lymphoma treated with brachytherapy. He continues to lead internationally in developing and deploying innovative brachytherapy techniques to expand the scope of practice, teaching and research.  

May 16, 2024 Sessions
14:30 - 15:30 3-D plesiotherapy for skin (MV)
May 17, 2024 Sessions
15:40 - 16:40 Skin lip cancer brachytherapy
May 18, 2024 Sessions
08:20 - 08:30 Brachytherapy for Hand and Foot Tumors
Shirin Enger, Physicienne médical

Shirin Enger, Physicienne médical

Mcgill University Health Center

Shirin A. Enger is a tenured associate professor at Gerald Bronfman Department of Oncology, McGill University, and Canada research chair in medical physics. Her main research interest is brachytherapy with an overall aim to enable patient-specific brachytherapy dose planning and delivery. She leads a research group with focus on novel brachytherapy technology. Dr. Enger completed her PhD at Uppsala University, Sweden in 2008, and her postdoctoral fellowship at Université Laval, Quebec, Canada during 2009 to 2011. During 2012 to 2014 she held a position as assistant professor in Medical Physics at Uppsala University prior moving to Montreal and her current position at McGill University.

William Foster, MD

William Foster, MD

Centre Hospitalier Universitaire de Québec

After completing his residency at the CHU de Québec, Dr Foster completed a fellowship in Genito-Urinary Oncology and Brachytherapy at the University of California in San Francisco (UCSF) Cancer center. Under the supervision of Dr I-Chow “Joe” Hsu, he learned how to use ultrasound-based image-guided brachytherapy in interstitial GYN oncology. He has since been an attending in Quebec City, where he could further develop the technique for both vaginal and locally advanced cervical cancer. In collaboration with his colleagues (physicians, physicist and therapists), he has been involved in multiple research projects regarding IGBT, helped introduce the new hybrid applicators in the clinic and was also actively involved in the development and design of a brand new brachytherapy facility where CT, MR and US are used to improve the quality of implants. He has also been involved in the training of many residents and fellows over the years, was an invited speakers in GYN brachytherapy conferences over the last years and is a standing member of the board of directors of the Canadian Association of Radiation Oncology (CARO).

May 17, 2024 Sessions
09:30 - 09:45 Vaginal Brachytherapy for Salvage Of Cervical Cancer
Mathieu Goulet, Physicien médical

Mathieu Goulet, Physicien médical

CRIC Lévis

Mathieu Goulet is a clinical medical physicist working at the Centre Régional Intégré de Cancérologie (CRIC) in Lévis, QC, Canada. He obtained his PhD in Physics from Laval University in 2014 and completed his residency in medical physics at McGill University and CHU de Québec in 2016. He contributed to the start of clinical activities at the CRIC in 2019 and was involved in developing the brachytherapy program at the same center. He has recently become an associated researcher at the Research Center of CISSS-CA, specializing in the applications of AI in radiation oncology. He describes himself as a fervent advocate of brachytherapy and other unicorn-related endeavors."

May 17, 2024 Sessions
14:30 - 14:50 Application of AI in prostate brachytherapy
Regis Heliou, Physicien médical

Regis Heliou, Physicien médical

Hôpital Charles Lemoyne

...

May 16, 2024 Sessions
14:30 - 15:30 3-D plesiotherapy for skin (MV)
May 17, 2024 Sessions
15:40 - 16:40 Cervix cancer MRI workflow (part 2)
Peter Hoskin, MD

Peter Hoskin, MD

Mount Vernon Hospital, UK

Peter Hoskin trained in clinical oncology at the Royal Marsden Hospital London and has been consultant in clinical oncology at Mount Vernon Cancer Centre, Northwood UK since 1992. He is also Professor in Clinical Oncology at University College London. Research interests focus on radiotherapy quality assurance, palliative radiotherapy, and brachytherapy. He chairs the GEC ESTRO urological brachytherapy group UROGEC and is a member of the GEC ESTRO committee and ESTRO Board as well as Clinical Editor for Radiotherapy and Oncology.

Joe Hsu, MD

Joe Hsu, MD

UCSF Helen Diller Family Comprehensive Cancer Center

Dr. I-Chow "Joe" Hsu is an internationally recognized radiation oncologist with special expertises in brachytherapy and hyperthermia. Dr. Hsu’s research investigates the application of Hight Dose Rate (HDR) brachytherapy, a highly precise and conformal treatment that delivers radiotherapy by temporarily placing a minute radioactive source in the tumor using minimal invasive, image guided procedures.  His research in hyperthermia, a moderate temperature elevation (40-45° C) of the targeted tumor, explores the synergy between thermal therapy and radiotherapy to improve treatment efficacy without increasing treatment related toxicity.  His research in the treatment of genitourinary and gynecologic malignancies have lead to improved clinical outcomes and effective novel treatments for challenging clinical conditions. Dr. Hsu earned a medical degree at the Johns Hopkins School of Medicine. He is an active member of American Society for Radiation Oncology, American Brachytherapy Society and Society for Thermal Medicine.  He has been recognized as a Fellow of American College of Radiology and as a Fellow of American Society for Radiation Oncology.

Fleur Huang, MD

Fleur Huang, MD

Cross Cancer Institute Edmonton

Dr. Fleur Huang is a radiation oncologist at the Cross Cancer Institute in Edmonton, and Associate Professor in the Department of Oncology at the University of Alberta, where she is a member of the Women and Children’s Health Research Institute. She maintains a busy clinical practice, with focus on women's cancers and palliative radiotherapy. Dr. Huang holds a medical degree from McGill University, where she also completed residency in Radiation Oncology. This was followed by Breast and Gynecologic subspecialty training at the Princess Margaret Hospital, University of Toronto. While growing her clinical practice, and deepening professional interests in Global Health and Health Systems, she earned an MPH at the Johns Hopkins Bloomberg School of Public Health. Dr. Huang has advanced her perspectives through study in places as diverse as the International Space University / Pôle Universitaire Européen de Strasbourg and Singapore Management University, more recently she was among the inaugural cohort of the NCI’s Multilevel Intervention Training Institute. In 2015, Dr. Huang led a team selected to take part in NCI-ASCO’s Teams in Cancer Care Delivery initiative (healthcaredelivery.cancer.gov/healthcare/nci-asco.html). She is a core member of CancerCare Alberta’s Brachytherapy Centre of Excellence working group. With broad-ranging activities in research and teaching, some of Dr. Huang’s latest multidisciplinary efforts have explored machine learning for predictive modeling of MRI uterine deformation from brachytherapy tandem placement, and first-in-kind prototyping of a virtual reality simulator for cervical brachytherapy intracavitary/interstitial applicator insertion. She has been participating in the EMBRACE Collaborative Group (www.embracestudy.dk) since her first study enrolment in 2011, and still leads the team that was among the top-10 accruers to EMBRACE-I.

Marjory Jolicoeur, MD

Marjory Jolicoeur, MD

Université de Montréal - Hôpital Charles Lemoyne

Dr. Jolicoeur had her medical degree along with a Ph.D in Molecular biology and completed her radiation oncology residency at University of Montreal in 1996. she completed a brachytherapy fellowship at the Centre Georges-François Leclerc located in Dijon France. In 1997 she started working at the department of Radiation Oncology of University of Montréal, where she still holds a position as a professor. In 1999 she was appointed to the planning and construction of the new department of Radiation Oncology of Hospital Charles LeMoyne. The facility, which started his activities in 2011, has a comprehensive image guided brachytherapy program. In 2011 she founded “Curietherapies”. As a brachytherapy specialist, she has special research interests in the application of brachytherapy in area such as breast, genitourinary and gynecologic cancers. Her main focus is in the development of image guided implant procedures, the use of MRI in brachytherapy and the precision delivery of conformal high dose rate brachytherapy.

Andrée Jutras, Technologue

Andrée Jutras, Technologue

CHUM

Andrée Jutras graduated from Ahuntsic College in 1994.  She has been a member of the brachytherapy team at the Centre Hospitalier de l'Université de Montréal since 2005 and has been Chief Brachytherapy Technologist since 2017.

May 17, 2024 Sessions
15:40 - 16:40 Patient welfare during brachytherapy
Mira Keyes, MD

Mira Keyes, MD

British Columbia Cancer Agency

Dr. Keyes is a Clinical Professor in Radiation Oncology, Division of Surgery, at University of British Columbia (UBC) in Vancouver.  British Columbia Cancer Agency Prostate Brachytherapy Program past QA chair and head of the program 2006 – 2016. She is a Fellow of American Brachytherapy Society (FABS), past board member and secretary for ABS, chair of Education Committee, and ASTRO and ABS Prostate Brachytherapy Workshops course director. In 2017, she was awarded ABS Presidents Award, for outstanding contribution to ABS. She is a member of the editorial board for Brachytherapy Journal.  Dr. Keyes is a Vice-Chair of the Royal College of Physicians and Surgeons of Canada AFC Diploma in Brachytherapy, a former Residency Training Program Director in Radiation Oncology at UBC, and past Royal College examiner.  She is a recipient of several UBC Radiation Oncology Residency Training Program awards and was nominated for Royal College of Physicians and Surgeons of Canada Mentorship Award.  Dr. Keyes is a keynote speaker, author of over 80 peer reviewed manuscripts and recipient of peer review grants including a CIHR and Michael Smith Foundation grant for translational research in prostate cancer. 

Gérard Lagmago, Physicien médical

Höpital Charles Lemoyne

...

May 17, 2024 Sessions
15:40 - 16:40 Skin lip cancer brachytherapy
Renée Larouche, Physicienne médical

Renée Larouche, Physicienne médical

Centre Hospitalier de l'Université de Montréal

Renée travaille comme physicienne médicale au CHUM depuis 2006. Ses principaux intérêts sont l'application de stratégies de gestion des risques à la radio-oncologie, la curiethérapie prostatique à faible débit (LDR) et à haut débit (HDR) et l'enseignement de la physique aux résidents en radio-oncologie. Renée fait partie de l'équipe de curiethérapie prostatique du CHUM depuis plus de dix ans. Elle était responsable de la mise en service du système UroNav avec reconstruction de cathéter électromagnétique pour une utilisation clinique pour la curiethérapie de la prostate HDR. Renée est également Chargée d’enseignement clinique à l’Université de Montréal et a été responsable du volet formation en physique du programme de résidence en radio-oncologie. En 2019, une révision complète du programme de physique et de la nouvelle structure des cours de physique pour mettre en œuvre la compétence par conception a été mise en œuvre. Renée a également fait du bénévolat au Collège canadien des physiciens en médecine (CCPM) pendant de nombreuses années, culminant avec le rôle d'examinateur en chef du CCPM de 2015 à 2018.

May 16, 2024 Sessions
14:30 - 15:30 LDR prostate brachytherapy (MV)
Eric Leung, MD

Eric Leung, MD

Sunnybrook Health Sciences Centre

Eric Leung is an Assistant Professor at the University of Toronto and a Clinician-Investigator in the Department of Radiation Oncology at Sunnybrook Odette Cancer Centre. He is originally from Saint John New Brunswick and graduated from medical school at the Memorial University of Newfoundland.  He completed his residency and fellowship training at U of T and specializes in interstitial and MR-guided brachytherapy.  Dr. Leung has an interest in cervical cancer clinical trials and is a member of the Cervix Core Committee at NRG Oncology and the Cervix Executive Committee at CCTG. His other academic interests include translational studies in cervix cancer including metabolic imaging for patients with locally advanced gynecological tumours. 

Tina Maillet, Patient Advocate

...

May 17, 2024 Sessions
09:45 - 09:50 Patient insight in brachytherapy
André-Guy Martin, MD

André-Guy Martin, MD

Centre Hospitalier Universitaire de Quebec

Fellowship en curiethérapie; Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA MSc médecine expérimentale; Faculté de médecine, University Laval, Québec, Québec “Diplôme d’étude supérieurs en radio-oncologie”; University Laval, Québec, Québec Doctorat en médecine; Faculté de médecine, Université Laval, Québec, Québec Bachelier en Pharmacie; École de pharmacie, Université Laval, Québec, Québec

May 16, 2024 Sessions
14:30 - 15:30 Rectal spacer
May 18, 2024 Sessions
13:50 - 14:00 Ultra-Hypofraction radiotherapy and Brachytherapy boost for High risk prostate cancer
Alvaro Martinez, MD

Alvaro Martinez, MD

21st Century Oncology of Michigan

Alvaro A. Martinez, M.D. received his medical degree from Universidad Javeriana in Bogota, Colombia. He completed a radiation oncology residency program at the Memorial Sloan-Kettering Cancer Center in New York. Following his residency, he became an Assistant Professor at Stanford University Medical School in Palo Alto, California. In 1981, he joined the department of Oncology at Mayo Clinic Medical School in Rochester, Minnesota where he achieved the position of Associate Professor. He was appointed Chairman of the department of Radiation Oncology at Beaumont Hospital Royal Oak, Michigan in 1985 where he was a Professor of Radiation Oncology at Oakland University William Beaumont Medical school. For the past five years, he has been a Senior VP of Scientific and Clinical Strategy at 21st Century Oncology of Michigan, a division of Michigan Health care professionals. Taking advantage of his surgical training, Dr. Martinez achieved outstanding expertise in brachytherapy and he designed special applicators which are widely used for the treatment of patients with gynecological and other pelvic malignancies. He is a member of numerous national and international professional organizations and is highly regarded by his peers for his professional accomplishments. He was president of the Michigan Society of Therapeutic Radiology in 1989 and president of the American Brachytherapy Society in 1991. Dr. Martinez is certified in radiation oncology by the American Board of Radiology and was awarded a fellowship in the American College of Radiology. Dr. Martinez has been a member of several National Cancer Institute review committees. He has been an associate editor for many national and international medical journals, and has contributed to more than 340 articles in prestigious scientific medical journals. In additional, he has written and contributed to more than 45 chapters in textbooks.

May 16, 2024 Sessions
14:30 - 15:30 Rectal spacer
May 17, 2024 Sessions
07:40 - 08:10 A Journey Through Brachytherapy
May 18, 2024 Sessions
08:55 - 09:05 Brachytherapy for pediatric tumors
15:00 - 16:00 Debate: HDR Monotherapy Dose: Are we there yet?
15:40 - 16:00 Discussion
Gorka Nagore, MD

Gorka Nagore, MD

Genesis Care Spain

Radiation oncologist with experience since 2003. He joined GenesisCare Spain in January 2007 in Alicante. In 2016 he moved to Madrid coordinating several centers and in 2018 he rejoined the Alicante coordination. Radiation oncologist, member of the Clinical Reference Group for Urological tumors of GenesisCare Spain, Member of the clinical Leader forum (CLF) and Leader of the national brachytherapy working group. Years of experience: Since 2003. Graduate in Medicine, University of Navarra. 1995-2002. Radiation oncologist, Navarra University Clinic. 2003-2007. Certified in Good Clinical Practice standards. Previous workplaces and professional experience Coordinator of GenesisCare Alicante (2007-2015). Coordinator of GenesisCare San Francisco de Asís Madrid and GenesisCare Torrejón de Ardoz (2016-2018). Tumor Committee at H. U. Torrejón (2016-2018), Urology at H. San Francisco de Asís (2016-2018), H. Vithas Alicante and SNC H. General Universitario de Alicante. GenesisCare National Brachytherapy Coordinator (2016-present) Coordinator of GenesisCare Alicante (2018-present). Scientific Publications Several scientific articles in international journals.

Jacquelin Paré, Patient Advocate

...

May 18, 2024 Sessions
11:15 - 11:20 Patient insight in brachytherapy
Alexandra Rink, Physicienne médical

Alexandra Rink, Physicienne médical

Princess Margaret Cancer Center

Alexandra Rink is a Lead Brachytherapy Physicist at the Princess Margaret Cancer Centre, a member of Ontario Health Gynecological Cancers Community of Practice, and an Assistant Professor in the Departments of Radiation Oncology and Medical Biophysics, at the University of Toronto. She completed her Ph.D. in the Department of Medical Biophysics under the co-supervision of Drs. Jaffray and Vitkin in 2008, focusing on in vivo methods for patient dosimetry.  After completing her Medical Physics residency at the University of Toronto, she joined the Medical Physics department at the Princess Margaret Cancer Centre in 2010. Alexandra’s passions are in vivo dosimetry and improvement in quality of care for brachytherapy patients through the application of Artificial Intelligence and Deep Learning methods. 

Marie-Pier St-Laurent, Technologue

Marie-Pier St-Laurent, Technologue

Hôpital Charles Lemoyne

Marie-Pier St-Laurent graduated from Collège de Ste-Foy as a radiation oncology technologist and has been working at Hôpital Charles Lemoyne ever since. She then worked as a brachytherapy technologist from 2013 to 2023. She has held the position of brachytherapy coordinator and is currently assistant head of the brachytherapy sector. She is concerned about the situation of brachytherapy patients and is always looking for new ideas to serve them better. Member of the curietherapi.es committee since 2022

May 17, 2024 Sessions
15:40 - 16:40 Patient welfare during brachytherapy
Arthur Sun Mynt, MD

Arthur Sun Mynt, MD

Clatterbridge Cancer Center NHS

Prof. Sun Myint graduated from IM (2) Yangon, Burma in 1972. He was appointed as a Clinical scientist for Medical Research Council’s Neutron trial project in 1983 and chaired the MRC colorectal sub-group for neutron trials until 1995. He was the named author for the third MRC/RTOG Neutron trial (BMJ 2091). He was the chair of TSG in Gastrointestinal malignancies at Clatterbridge Centre for Oncology (1998-2012) where he worked as a consultant for over 35 years. His main research interest is in the treatment of rectal cancers by brachytherapy. He introduced contact X-rays brachytherapy (Papillon) into the UK and started treating patients at Clatterbridge from 1993. So far, he has treated over 3000 patients using Papillon technique which is the world largest cohort of patients. He helped design a new contact radiotherapy machine together with his mentor Prof Jean Pierre Gerard in collaboration with Ariane Company. He is the director of annual Papillon course at Clatterbridge (2010-present). 

May 18, 2024 Sessions
09:15 - 09:25 Dose Escalation with brachytherapy for Rectal Cancer
Aman Taggar, MD

Aman Taggar, MD

Sunnybrook Health Sciences Centre

Dr. Amandeep Taggar is originally from Vancouver and completed his medical school training at the University of British Columbia. He also did his Masters in Advanced Therapeutics and Oncology at the University of British Columbia. He completed his residency in the Department of Radiation Oncology at the Tom Baker Cancer Center at the University Of Calgary, and his fellowship in the Department of Radiation Oncology at the Memorial Sloan Kettering Cancer Center in New York. He currently is an Assistant Professor in Radiation Oncology at the University of Toronto and a Clinician-Investigator at the Odette Cancer Centre/ Sunnybrook Health Sciences Centre. He specializes in treating patients with gynecologic and Upper gastrointestinal malignancies and his practice involves MRI guided radiotherapy and brachytherapy/interstitial brachytherapy.

May 17, 2024 Sessions
08:10 - 08:30 Role of Interstitial Brachytherapy in Cervical Cancer
May 18, 2024 Sessions
09:05 - 09:15 HDR Brachytherapy for Biliary Tract Cancer
Vincent Turgeon, Physicien médical

Vincent Turgeon, Physicien médical

Vincent Turgeon is a medical physicist certified by the Canadian College of Physicists in Medicine since 2021. He completed his Master's degree in Medical Physics at McGill University, where he had the opportunity to work under the supervision of Professor Shirin Enger, a leading researcher in the field. After graduating, Vincent Turgeon completed his residency in medical physics at the Jewish General Hospital, where he acquired valuable expertise. He worked with dedication

May 16, 2024 Sessions
14:30 - 15:30 Hands-on breast Implant (part 1)
May 17, 2024 Sessions
15:40 - 16:40 Hands-on breast implant (part 2)
Eric Vigneault, MD

Eric Vigneault, MD

CHUQ

Dr. Eric Vigneault received his medical degree from the University of Montreal in 1992. In addition to completing his residency training in radiation oncology at the CHUQ Hôtel-Dieu de Quebec Hospital in 1997, Dr. Vigneault obtained a Master of Science degree in experimental medicine in 1996. He also completed a one year and a half fellowship in brachytherapy and three-dimensional external beam radiation therapy at the University of California San Francisco under the supervision of Dr. Mack Roach in 1998. He is involved in brachytherapy at both the provincial and national levels, as Chair of the Province of Quebec brachytherapy committee, and was president of the Canadian Brachytherapy Group from 2002 to 2006. Dr Vigneault was head of the Hotel-Dieu of Quebec Radiation-Oncology Department from 2003 to 2007. Since September 2015 Dr Vigneault is the president of the Canadian Association of Radiation Oncology and the Titular of the new Research Chair on Image Guided Brachytherapy

May 16, 2024 Sessions
14:30 - 15:30 LDR prostate brachytherapy (MV)
May 18, 2024 Sessions
11:30 - 13:00 Lunch Break